ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
¾ÅÔÂ×ðÁú¿Ê±½«Ö÷Àí1³¡ÏßÉÏÖ±²¥£¬Í¬Ê±¼ÓÈë8³¡º£ÄÚÍâ¾Û»á£¬³ÏÑûÁÐλҵ½çͬÈÊݰÁÙÏÖ³¡£¬ÓëÎÒÃÇÅöײÖǻۣ¬ÅäºÏ̽ÌÖÒ©ÎïÑз¢µÄË¢ÐÂ֮·¡£
August 31-September 4, 2025
Rio de Janeiro, Brazil
The World Congress on Alternatives and Animal Use in the Life Sciences (WC series) was established by the Alternatives Congress Trust in Baltimore, USA in 1993 to bring together multidisciplinary stakeholders from academia, industry, government, and non-profit sectors under one roof to advance the 3Rs-to reduce, refine, and replace the use of animals in the life sciences.
Prof. Shuangqing Peng (Medicilon CSO) is invited to deliver keynote presentations "The Evolution of Non-Animal Testing in China: Opportunities and Challenges Under CSAR" and "Non-Animal Toxicity Testing Strategies in China£ºDevelopment and Challenges" at WC13.
August 31-September 4, 2025
Porto, Portugal
Medicilon Booth #32
The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. This symposium will bring together chemists from around the world and will focus on the latest advances in strategies and methodologies across synthetic chemistry, medicinal chemistry, chemical biology and drug discovery. Engage with the Medicilon Europe team and discover how Medicilon can accelerate your research progress and achieve breakthroughs.
September 14-17, 2025
Megaron Concert Hall, Athens, Greece
Medicilon Booth#A59
The theme of Eurotox 2025, ¡°Toxicology addresses Society¡¯s real-life risks for sustainable health and well-being,¡± addresses this need. Eurotox 2025 aims to be the key platform so as to advance this approach and develop practical programs that safeguard health and sustainability. Dr. Renzong Xie (VP of Toxicology) and Dr. Paul G.J. van Stralen (VP of Strategic Collaborations EMEA) will be present throughout the conference. Please stop by at our booth and explore unparalleled experience in non-clinical toxicology studies services (GLP and non-GLP).
September 14-17, 2025
Cambridge, England
The 23rd SCI-RSC Medicinal Chemistry symposium is Europe¡¯s premier biennial Medicinal Chemistry event, focusing on first disclosures and new strategies in Medicinal Chemistry. This is a great opportunity to accelerate your learning curve in medicinal chemistry, learning from your peers and our experts and it¡¯s a lot of fun to play! Meet Dr. George Buckley to explore how Medicilon can support your R&D goals with our integrated platform.
September 17-18, 2025
Vilnius, Lithuania
Life Sciences Baltics is the leading event in the Baltic region, connecting global life sciences professionals. It provides unique opportunities for project initiation, lead generation, and strategic partnerships through an extensive exhibitor showcase, insightful conferences, a dedicated partnering area, diverse networking formats, and competitions, including a startup pitch challenge. Dr. Wei Hu is happy to meet you to discuss how our services and capabilities would support your current research needs and expedite your drug discovery and development programs.
September 18-20, 2025
Hong Kong Science Park
Medicilon Booth #TBD
The objective of this forum is to provide a dynamic platform for leading scientists to exchange insights and address emerging challenges in the fields of aging and age-associated diseases. With an anticipated attendance of 120+ delegates, including the founder from International Society on Aging and Disease, editors from high impact-factor journals, leading academics from top academic institutions, and industry pioneers.
September 22-25, 2025
Boston, MA
Medicilon Booth#316
Discovery on Target (DOT), now in its 23rd year, is a leading event focused on innovative drug targets, modalities, technologies, and strategies. This 4-day event offers insights into novel therapeutic discovery and development, from small molecules to biologics, covering target identification, lead generation, cancer therapies, protein degradation, AI/machine learning, and more. This year features expanded coverage of GLP-1, MASH and obesity, ADCs, bispecifics, and small molecules targeting DNA. Join us to meet the Medicilon US team and discover our comprehensive suite of R&D solutions, spanning chemistry to IND filing.
2025Äê9ÔÂ23-24ÈÕ
±±¾©ÀÊÀö×ÈÎ÷ɽ»¨Ô°ÂùÝ
×ðÁú¿Ê±Õ¹Î» #TBD
µÚ4½ìBIONNOVA±±¾©Á¢ÒìÂÛ̳½«ÓÚ2025Äê9ÔÂ23-24ÈÕ¾«²ÊÆô³Ì¡£Ê×ÅúÈ·ÈϳöϯµÄ90+λȨÍþ¼Î±ö£¬À´×Ô¿ç¹úÒ©Æó¡¢±¾ÍÁÁúÍ·¡¢Biotech¡¢¿ÆÑÐÔºËùÓëÁÙ´²Ò»ÏßµÈÆóÒµ/»ú¹¹£¬½«Î§ÈÆ¿¹ÌåÒ©Îϸ°ûÓë»ùÒòÖÎÁÆ¡¢Ð¡·Ö×ÓÁ¢ÒìÒ©¡¢ÖØ´óÖÆ¼Á¡¢ºËËáÓë¶àëÄÒ©Îï¡¢ÁÙ´²Óë×¢²áÉ걨µÈÒªº¦ÁìÓòÕö¿ªÌÖÂÛ¡£
×ðÁú¿Ê±ÆÕÑÇ´¨É³site»ú¹¹ÈÏÕæÈË×Þºº¾ü²©Ê¿½«³öϯСºËËáÓëmRNA¾Û½¹ÂÛ̳²¢·¢Ñݳö½²¡£×ðÁú¿Ê±ÉÌÎñÍŶӽ«ÔÚÏÖ³¡È«³ÌÉèÕ¹£¬³ÏÑûÄúݰÁÙÏÖ³¡½»Á÷£¡
marketing@medicilon.com
ýÌåÓë»áÎñÇëÁªÏµ
×ðÁú¿Ê±Êг¡²¿Î¢ÐÅ»òÓÊÏä